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Introduction
Arthrogyposis multiplex congenita (AMC) is due to a wide range of neurological and neuromuscular causes, the latter comprising a wide spectrum of genetically heterogenous congenital myopathies [1] . In addition to skeletal deformities such as multiple contractures, scoliosis and thoracic deformities, severely affected newborns may present with additional respiratory insufficiency, facial weakness, swallowing problems, and severe muscular hypotonia (as well as hypertonic muscle tone in extremely rare cases) [2] [3] [4] . The risk for intrauterine death as a consequence of severe fetal akinesia is well documented [5] . Muscle biopsy and confirmatory genetic testing are diagnostically most relevant, although non-specific myopathic changes may delay the correct diagnosis in newborns and young infants [1, 6] . Mutations in the skeletal muscle ryanodine receptor (RYR1) gene, encoding the principal sarcoplasmic reticulum (SR) Ca2+ release channel with a crucial role in excitationcontraction coupling (ECC), are increasingly recognized as a common cause of various congenital myopathies [2, [7] [8] : Whereas dominant mutations affecting mutational hotspots within the RYR1 gene are mainly associated with the malignant hyperthermia susceptibility trait (MHS), a pharmacogenetic predisposition to severe adverse reactions in response to halogenated anaesthetics and muscle relaxants (for review [9] ), and the congenital myopathy Central Core Disease (CCD) [10] , recessive mutations distributed throughout the RYR1 coding sequence give rise to a wide clinical-pathologic spectrum including Multi-minicore Disease (MmD) [11] , Centronuclear Myopathy (CNM) [12] , and Congenital Fiber Type Disproportion (CFTD) [13] .
Most patients with RYR1-associated myopathies present in infancy or early childhood with mild or moderate muscular hypotonia and motor developmental delay. In Page 3 of 22 addition, adult myopathic presentations [14] [15] such as late-onset axial myopathy [16] [17] , or induced manifestations such as exertional myalgia/rhabdomyolysis (ERM) [18] are increasingly recognized, in particular in association with MHS-predisposing RYR1 mutations. At the other end of the spectrum, severe neonatal manifestations associated with both (often de novo) dominant and recessive RYR1 mutations have been reported [3] [4] . In these patients decreased fetal movements, arthrogryposis multiplex congenita (AMC), polyhydramnios, scoliosis and respiratory distress are typically observed [1, [3] [4] 19] . Recently, several cases with a lethal neonatal course have been documented [20] , some of those within the spectrum of the "lethal multiple pterygium syndrome" [5] . Intrafamilial phenotypic variability has been reported in several families affected by such severe presentations [4, 20] .
Lately, bleeding abnormalities have been described in patients with RYR1 mutations, in particular mutations also associated with the MHS trait and/or ERM [21] . This clinically relevant observation was confirmed and its molecular basis elucidated in an animal model of RYR1-associated malignant hyperthermia, the Y522S mouse [21] .
Here we report complications of unexpectedly severe CNS bleeding in an infant with RYR1-associated AMC and a complex myopathic pattern comprising dystrophic features and eccentric cores on muscle biopsy.
Case report
This male infant was born to healthy non-consanguineous parents. The mother had Using high frequency oscillation ventilation (HFO) respiratory parameters could be temporarily stabilized, but change to conventional modes of ventilation was not tolerated until the 14th day of life. CT scan of the lungs did not reveal any specific pulmonary abnormality. Subsequently, Neurally Adjusted Ventilatory Assist (NAVA) ventilation was successfully introduced and tolerated. At the age of 7 months tracheotomy had to be performed to enable ambulatory assisted ventilation and home care.
Cranial MRI at the age of 8 weeks showed sequelae of a 2° hemorrhage arising from the left caudothalamic groove as well as a spinal epidural space-occupying lesion from cervical spine 5 to thoracic spine 9, suggesting an organized prenatal hemorrhage (Fig.2) . Progressively abnormal increase in head circumference led to the diagnosis of post-hemorrhagic hydrocephalus internus, presumably caused by prenatal intracranial hemorrhage and confirmed on cranial ultrasound. Ventriculoperitoneal shunting was performed at the age of 4 months.
Chromosomal analysis and molecular genetic analysis of SMN1, IGHMBP2, MTM1
and DMPK genes excluded the clinically most relevant differential diagnoses. Here we report a patient with a severe RYR1-associated early-onset myopathy, comprising features of arthrogryposis multiplex congenita (AMC), profound respiratory impairment and additional evidence of CNS bleeding of prenatal origin. In terms of overall severity, our patient falls within the severe end of recessive RYR1-related myopathies, where patients may be premature and present with breathing and feeding difficulties requiring ventilation support and gastrostomy feeds [1, 3, 22] .
The patient was found to be compound heterozygous for a maternally inherited RYR1 c.6488G>A mutation, previously associated with MHS and cores on muscle biopsy [23] , and a paternally inherited RYR1 c.14918C>T mutation also previously implicated in the MHS trait [24] [25] supporting the notion that some RYR1 mutations behave as dominants with regards to the MHS trait but as recessives with regards to congenital myopathy phenotypes [7, 26] . Exome sequencing did not show any other mutations in our patient. Recessive RYR1-related myopathies are predominantly due to compound heterozygosity for RYR1 loss-of-function mutations and missense mutations, the latter also occasionally associated with the MHS trait [7] [8] 15] .
Compound heterozygosity or homozygosity for MHS-associated RYR1 mutations is less common, but has been reported in some patients with widely variable clinical- Interestingly, our patient had additional features of two-stage CNS bleeding events that for several reasons are more likely to be due to his genetic background rather than his gestation: Firstly, prenatal intraventricular hemorrhage (IVH) is common in very preterm infants but incidence decreases with advancing gestational age and becomes increasingly rare after 32 weeks gestation [29] . Secondly, epidural hematoma affecting the brain is uncommon after atraumatic birth [30] specific RYR1 antagonist dantrolene in the management of subarachnoid hemorrhage and other traumatic CNS events with a vascular component [34] [35] .
We conclude that this report adds to the phenotypic variability of RYR1 mutations and may draw the attention of clinicians and researchers to the possibility of hemorrhagic complications associated with RYR1 mutations.
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